Clinical Trials
Search Form
Disease Site | Trial | Trial Description | Trial Status Sort descending | Lead Cooperative Group |
---|---|---|---|---|
Cervical | Empower Cervical 1/ ENGOT-Cx9/ GEICO 72-C/ GOG-3016 |
An Open Label, Randomized, Phase 3 Clinical Trial of REGN2810 Versus Therapy of Investigator’s Choice Chemotherapy in Recurrent or Metastatic Platinum-Refractory Cervical Carcinoma |
Completed | GEICO |
Cervical | MITO CERV 2 |
Study of Adding Cetuximab to Chemotherapy for the Treatment of Advanced and/or Recurrent Cervical Cancer (MITO CERV 2) |
Completed | MITO |
Cervical/Endometrial | GOG233/ACRIN6671 |
Fludeoxyglucose F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial Cancer |
Closed to Recruitment | GOG-F |
Endometrial | MK-2870-005-ENGOT-en23 |
A Phase 3, Randomized, Active-controlled, Open-label, Multicenter Study to Compare the Efficacy and Safety of MK-2870 Monotherapy Versus Treatment of Physician’s Choice in Participants With Endometrial Cancer Who Have Received Prior Platinum-based Chemotherapy and Immunotherapy |
Pending | MITO |
Endometrial | SAVE |
Short Course Adjuvant Vaginal Cuff Brachytherapy (VCB) in Early Endometrial Cancer Compared to Standard of Care (SAVE) |
Recruiting | COGI-WCRN |
Endometrial | AEC |
Cytoreductive Surgery in Advanced Endometrial Cancer. Multicenter Retrospective Study |
Recruiting | MITO |
Endometrial | E.C.Co. |
Endometrial Cancer Conservative treatment. A multicentre archive |
Recruiting | MITO |
Endometrial | Rainbo-MMRd-GREEN |
Rainbo: Refining adjuvant treatment IN endometrial cancer based on molecular features, transportec platform trials - MMRd - Green |
Recruiting | DGOG |
Endometrial | C93GOG-3064 ENGOT-en15 |
A Phase 3 Randomized, Open-label, Active-comparator Controlled Clinical Study of Pembrolizumab versus Platinum Doublet Chemotherapy in Participants With Mismatch Repair Deficient (dMMR) Advanced or Recurrent Endometrial Carcinoma in the First-line Setting |
Recruiting | MITO |
Endometrial | AGO-OP.6/ECLAT |
Endometrial Cancer Lymphadenectomy Trial (ECLAT) |
Recruiting | AGO |
Endometrial | KGOG 2029/ SELYE |
Randomized comparison between sentinel lymph node mapping using indocyanine green plus a fluorescent camera versus lymph node dissection in clinical stage I-II endometrial cancer: a Korean Gynecologic Oncology Group trial |
Recruiting | KGOG |
Endometrial | ENGOT-EN20/GOG-3083/XPORT-EC-042 |
A Phase 3, Randomized, Placebo-Controlled, double-blind, multicenter trial of selinexor in maintenance therapy after systemic therapy for patients with p53 wild-type, advanced or recurrent endometrial carcinoma |
Recruiting | BGOG |
Endometrial | DOMENICA |
Randomized phase III trial in MMR deficient endometrial cancer patients comparing chemotherapy alone versus Dostarlimab in first line advanced/metastatic setting |
Recruiting | GINECO |
Endometrial | CCTG EN.10: RAINBO BLUE AND TAPER |
A Phase II Study of Tailored Adjuvant Therapy in POLE-mutated and p53-wildtype/NSMP Early Stage Endometrial Cancer (RAINBO BLUE & TAPER) |
Recruiting | CCTG |
Endometrial | PORTEC-3 |
Randomized Phase III Trial Comparing Concurrent Chemoradiation and Adjuvant Chemotherapy with Pelvic Radiation Alone in High Risk and Advanced Stage Endometrial Carcinoma |
Closed to Recruitment | DGOG |
Endometrial | GOG 0258 |
Carboplatin and Paclitaxel with or Without Cisplatin and Radiation Therapy in treating Patients with Stage I, Stage II and Sage III or Stage IVA Endometrial Cancer |
Closed to Recruitment | GOG-F |
Endometrial | PORTEC-4a |
Randomised Phase III Trial of molecular profile-based versus standard recommendations for adjuvant radiotherapy for women with early stage endometrial cancer |
Closed to Recruitment | DGOG |
Endometrial | ENGOT-EN2 / DGCG |
A phase II Trial of postoperative chemotherapy or no further treatment for patients with node-negative stage I-II intermediate or high risk endometrial cancer. |
Closed to Recruitment | NSGO-CTU |
Endometrial | ENGOT-EN3 / NSGO - PALEO |
Trial of Letrozole +/- Palbociclib in Metastatic Endometrial Cancer |
Closed to Recruitment | NSGO-CTU |
Endometrial | ENGOT-EN5/GOG- 3055/SIENDO |
A randomized, double-blind, phase 3 trial of maintenance with selixexor/placebo after combination chemotherapy for patients with advanced or recurrent endometrial cancer. |
Closed to Recruitment | BGOG |